During the past decade, Memorial Hospital conducted 87 clinical trials. In the 10-year time frame, 87 clinical trials started and 52 clinical trials were completed, i.e. on average, 59.8% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 43 clinical trials were completed. i.e. 477.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Memorial Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 52 trials, followed by "SWOG Cancer Research Network" with 24 trials sponsored, "Alliance for Clinical Trials in Oncology" with 14 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 8 trials sponsored and "Vanderbilt-Ingram Cancer Center" with 8 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Memorial Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 57 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator and "Agenus Inc." with 1 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Memorial Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Recurrent Breast Carcinoma" (6 trials), "Recurrent Ovarian Carcinoma" (6 trials), "Stage IIIA Breast Cancer" (6 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials). Many other conditions were trialed in "Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Memorial Hospital" are "Drug" (92 trials), "Other" (73 trials), "Biological" (50 trials), "Procedure" (27 trials) and "Radiation" (13 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (46 trials), "Quality-of-Life Assessment" (23 trials), "Nivolumab" (15 trials), "Cisplatin" (14 trials) and "Carboplatin" (13 trials). Other intervention names were less common.

The vast majority of trials in "Memorial Hospital" are 100 trials for "All" genders, 27 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Memorial Hospital". undefined are not yet recruiting, 15 are recruiting, 69 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 33 completed trials in Memorial Hospital, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Memorial Hospital, 3 "Phase 1" clinical trials were conducted, 59 "Phase 2" clinical trials and 58 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 10 trials that are defined as “Not Applicable".

Memorial Hospital has several departments that took part in Clinical trials: "Memorial Hospital Cancer Center - Chattanooga" - 4 trials